Public Profile

Pharma Core

Pharma Core, a leading player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in [year], the company has established itself as a key innovator in drug development and manufacturing, focusing on areas such as biotechnology, generic pharmaceuticals, and active pharmaceutical ingredients (APIs). Pharma Core is renowned for its commitment to quality and compliance, offering a diverse range of products that cater to various therapeutic needs. Its unique approach to research and development has led to significant advancements in treatment options, positioning the company as a trusted partner in healthcare. With a strong market presence and notable achievements in regulatory approvals, Pharma Core continues to drive progress in the pharmaceutical sector, ensuring access to essential medicines worldwide.

DitchCarbon Score

How does Pharma Core's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

Pharma Core's score of 0 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

20%

Pharma Core's reported carbon emissions

Pharma Core, headquartered in CN, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Pharma Core may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Pharma Core to establish clear emissions reduction goals and commitments to align with global climate standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pharma Core's primary industry is Financial intermediation services, except insurance and pension funding services (65), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Pharma Core is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pharma Core is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Financial Intermediation

Crédit Agricole CIB

FR
Financial Intermediation
Updated 6 days ago

PETRONAS Marketing International Sdn. Bhd.

MY
Financial Intermediation
Updated about 21 hours ago
CDP

Hyakujushi Bank

JP
Financial Intermediation
Updated 11 days ago

Shandong International Trust Co

CN
Financial Intermediation
Updated 11 days ago

Nse Clearing Limited

IN
Financial Intermediation
Updated 11 days ago

Merrill Lynch International Holdings, Inc.

US
Financial Intermediation
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers